Leroy Cantrell v. HHS - Influenza, Guillain-Barré syndrome (2023)
Case summary [AI summaries can sometimes make mistakes]
Leroy Cantrell filed a petition for compensation under the National Vaccine Injury Compensation Program on October 7, 2020, alleging that he suffered Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on October 4, 2018. His amended petition was filed on August 11, 2021.
Mr. Cantrell alleged that he received the vaccine in the United States, experienced residual effects for more than six months, and had no prior award or settlement.
The respondent denied that Mr. Cantrell sustained a GBS Table injury or that the flu vaccine caused his condition.
Nevertheless, on August 7, 2023, the parties filed a joint stipulation agreeing to an award of compensation. Chief Special Master Brian H.
Corcoran adopted the stipulation, awarding Mr. Cantrell a lump sum of $95,000.00 for all items of damages.
The decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses. Petitioner counsel was Sean Franks Greenwood, and respondent counsel was Martin Conway Galvin.
Theory of causation
Petitioner Leroy Cantrell alleged that he suffered Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on October 4, 2018. The respondent denied that petitioner sustained a GBS Table injury or that the flu vaccine caused his alleged injury. The parties filed a joint stipulation on August 7, 2023, agreeing to an award of compensation. Chief Special Master Brian H. Corcoran adopted the stipulation on August 8, 2023, awarding a lump sum of $95,000.00 for all items of damages. The public decision does not detail the specific mechanism of causation, expert testimony, or the medical evidence considered. Petitioner counsel was Sean Franks Greenwood, and respondent counsel was Martin Conway Galvin.
Source PDFs
USCOURTS-cofc-1_20-vv-01343